Difference between revisions of "Part:BBa K3890004"

Line 24: Line 24:
  
  
 
+
https://static.igem.org/mediawiki/parts/8/87/T--USP-Brazil--IGEM-USP-Description-Fusionedcyp2.png
 
+
 
+
 
+
 
+
  
 
Figure 2. Schematic representation of the novel CYP6G1 fused to NADPH-dependent cytochrome P450 reductase (CPR) by the flexible linker (GGGGS)x5. The N-terminal sequence of the membrane-anchoring CPR was removed to support the protein movement and rising the electron transfer efficiency. CYP6G1, cytochrome P450 monooxygenase; CPR, cytochrome P450 reductase; FAD, flavin adenine dinucleotide; FMN, flavin mononucleotide; NADPH, reduced nicotinamide adenine dinucleotide phosphate.
 
Figure 2. Schematic representation of the novel CYP6G1 fused to NADPH-dependent cytochrome P450 reductase (CPR) by the flexible linker (GGGGS)x5. The N-terminal sequence of the membrane-anchoring CPR was removed to support the protein movement and rising the electron transfer efficiency. CYP6G1, cytochrome P450 monooxygenase; CPR, cytochrome P450 reductase; FAD, flavin adenine dinucleotide; FMN, flavin mononucleotide; NADPH, reduced nicotinamide adenine dinucleotide phosphate.
Line 34: Line 30:
  
 
The artificial fusion of both parts through this linker reduces the molar ratio from 15:1 to 1:1 between CPR and CYP6G1, respectively [4]. This means a higher electron transfer efficiency from the NADPH cofactor to the CYP6G1 enzyme, promoting much higher enzymatic turnover rates compared to the unfused CYP6G1 [4]. Consequently, this high turnover rate allows the enzyme to efficiently catalyze (e.g., hydroxylate) a greater amount of the substrate (i.e, imidacloprid) thus improving the enzymatic catalysis of CYP6G1.
 
The artificial fusion of both parts through this linker reduces the molar ratio from 15:1 to 1:1 between CPR and CYP6G1, respectively [4]. This means a higher electron transfer efficiency from the NADPH cofactor to the CYP6G1 enzyme, promoting much higher enzymatic turnover rates compared to the unfused CYP6G1 [4]. Consequently, this high turnover rate allows the enzyme to efficiently catalyze (e.g., hydroxylate) a greater amount of the substrate (i.e, imidacloprid) thus improving the enzymatic catalysis of CYP6G1.
 
 
  
  

Revision as of 23:42, 21 October 2021


CYP6G1 fusioned with NADPH reductase

CYP6G1 fusioned with NADPH reductase

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BglII site found at 1947
    Illegal BglII site found at 3291
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI site found at 711
    Illegal BsaI.rc site found at 341
    Illegal BsaI.rc site found at 3242
    Illegal SapI.rc site found at 1822